Kelly Isbell

Research Specialist at KeViRx, Inc. - Charlottesville, Virginia, United States

Kelly Isbell's Colleagues at KeViRx, Inc.
Gary Cupit

Chairman of the Board

Contact Gary Cupit

John Lazo

Chief Scientific Officer

Contact John Lazo

John Lazo

Chief Scientific Officer

Contact John Lazo

Kelly Isbell's Contact Details
HQ
Location
Charlottesville,Virginia,United States
Company
KeViRx, Inc.
Kelly Isbell's Company Details
KeViRx, Inc. logo, KeViRx, Inc. contact details

KeViRx, Inc.

Charlottesville, Virginia, United States • 5 Employees
Research

KeViRx develops small molecule therapeutics for cancer and other diseases. Our lead compound, KVX-053, is a potent allosteric and selective phosphatase of regenerating liver 3 (PRL3, or PTP4A3) inhibitor. This target phosphatase is overexpressed in various cancers, including drug resistant ovarian cancer, and is believed to activate pathways enabling cancer cell migration and metastasis. KVX-053 displays promising activity in cell-based models of ovarian cancer and leukemia, as well as anti-tumor activity in in vivo models of ovarian cancer and acute myeloid leukemia.

Details about KeViRx, Inc.
Frequently Asked Questions about Kelly Isbell
Kelly Isbell currently works for KeViRx, Inc..
Kelly Isbell's role at KeViRx, Inc. is Research Specialist.
Kelly Isbell's email address is ***@kevirx.com. To view Kelly Isbell's full email address, please signup to ConnectPlex.
Kelly Isbell works in the Research industry.
Kelly Isbell's colleagues at KeViRx, Inc. are Gary Cupit, John Lazo, John Lazo and others.
Kelly Isbell's phone number is
See more information about Kelly Isbell